Thyroid dysfunction during PD‑1 inhibitor treatment in patients with cancer: Incidence and association with progression‑free survival-Reference-Cited by-同舟云学术

Thyroid dysfunction during PD‑1 inhibitor treatment in patients with cancer: Incidence and association with progression‑free survival

Published:2022-07-13 Issue:3 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wu Yanfei¹,Wang Zhi²,Bai Hongxia³,Gao Yan⁴

Affiliation:

1. Department of Pathology, Navy Medical Center of People Liberation Army, Naval Medical University, Shanghai 200433, P.R. China

2. Department of Nuclear Radiation Injury Protection and Treatment, Navy Medical Center of People Liberation Army, Naval Medical University, Shanghai 200433, P.R. China

3. Department of Pulmonary and Critical Care Medicine, Baotou Central Hospital, Baotou, Inner Mongolia Autonomous Region 014040, P.R. China

4. Department of Nuclear Medicine, Baotou Tumor Hospital, Baotou, Inner Mongolia Autonomous Region 014030, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference24 articles.

1. PD-1 and PD-L1 in cancer immunotherapy: Clinical implications and future considerations;Jiang;Hum Vaccin Immunother,2019

2. Roles of PD-1/PD-L1 pathway: Signaling, cancer, and beyond;Ai;Adv Exp Med Biol,2020

3. PD-1/PD-L1 pathway: Current researches in cancer;Han;Am J Cancer Res,2020

4. Pd-L1;Kythreotou;J Clin Pathol,2018

5. Landscape of PD-1/PD-L1 regulation and targeted immunotherapy;Ni;Chin Med Sci J,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Effector Jurkat Cell Activity and Increasing Cytotoxicity against A549 Cells Using Nivolumab as an Anti-PD-1 Agent Loaded on Gelatin Nanoparticles;Gels;2024-05-21

2. Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer;Heliyon;2024-03

3. Immune-related thyroid dysfunction in patients with non-small cell lung cancer;Journal of Thoracic Disease;2024-01

4. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity;Cancer Cell;2023-03